The anticancer effect of mebendazole may be due to M1 monocyte/macrophage activation via ERK1/2 and TLR8-dependent inflammasome activation
暂无分享,去创建一个
Claes R. Andersson | M. Jarvius | K. Blom | C. Andersson | R. Larsson | M. Fryknäs | P. Nygren | A. Loskog | J. Rubin | W. Senkowski | L. Lenhammar | M. Berglund | V. Parrow | Wojciech Senkowski